Status:
UNKNOWN
Treatment of Chronic Anemia With Epoetin Alfa in Elderly
Lead Sponsor:
Research and Education Foundation of Michael Reese Hospital
Collaborating Sponsors:
Ortho Biotech Clinical Affairs, L.L.C.
Cook County Health
Conditions:
Anemia
Eligibility:
All Genders
65+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine if chronic anemia can be corrected with epoetin alfa and does the subsequent correction lead to an improvement in fatigue,quality of life or mobility among el...
Detailed Description
Chronic Anemia is common among elderly. Given their somewhat non-specific nature, the clinical symptoms of anemia are often difficult to attribute directly to the anemia itself. However, it is known t...
Eligibility Criteria
Inclusion
- 65 years of age or older Diagnosed with chronic anemia Hemoglobin level less than or equal to 11.5 g/dl Community dwelling Able to make monthly clinic visits
Exclusion
- Currently on Epoetin alfa or similar preparations Having nutritional anemia Having active cancer or received recent treatment for cancer On treatment for Kidney disease Diagnosis of dementia Inability to ambulate
Key Trial Info
Start Date :
January 1 2003
Trial Type :
INTERVENTIONAL
End Date :
July 1 2005
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT00337441
Start Date
January 1 2003
End Date
July 1 2005
Last Update
June 16 2006
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
John H. Stroger Jr. Hospital of Cook County
Chicago, Illinois, United States, 60612
2
Mercy Hospital and Medical Center
Chicago, Illinois, United States, 60616-2477